Prothena (PRTA)
NASDAQ:PRTA
Holding PRTA?
Track your performance easily

Prothena (PRTA) Technical Analysis

573 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
2Neutral
15Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Prothena’s (PRTA) Moving Averages Convergence Divergence (MACD) indicator is -0.96, suggesting Prothena is a Sell.
Prothena’s (PRTA) 20-Day exponential moving average is 17.21, while Prothena’s (PRTA) share price is $15.3, making it a Sell.
Prothena’s (PRTA) 50-Day exponential moving average is 18.78, while Prothena’s (PRTA) share price is $15.3, making it a Sell.

Prothena (PRTA) Pivot Points

Nov 05, 2024, 05:37 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
15.20
15.73
16.00
16.53
16.80
17.33
17.60
Fibonacci
15.73
16.04
16.22
16.53
16.84
17.02
17.33
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Prothena (PRTA) Moving Averages

Nov 05, 2024, 05:37 AM
Period
Simple
Exponential
MA5
16.24Sell
16.14Sell
MA10
16.67Sell
16.52Sell
MA20
16.71Sell
17.21Sell
MA50
19.44Sell
18.78Sell
MA100
20.48Sell
20.43Sell
MA200
23.02Sell
24.01Sell
Prothena’s (PRTA) 10-Day exponential moving average is 16.52, while Prothena’s (PRTA) share price is $15.3, making it a Sell.
Prothena’s (PRTA) 100-Day exponential moving average is 20.43, while Prothena’s (PRTA) share price is $15.3, making it a Sell.
Prothena’s (PRTA) stock price is $15.3 and Prothena’s (PRTA) 50-day simple moving average is 19.44, creating a Sell signal.
Prothena’s (PRTA) stock price is $15.3 and Prothena’s (PRTA) 100-day simple moving average is 20.48, creating a Sell signal.
Prothena’s (PRTA) stock price is $15.3 and Prothena’s (PRTA) 200-day simple moving average is 23.02, creating a Sell signal.

Prothena (PRTA) Technical Indicators

Nov 05, 2024, 05:37 AM
Name
Value
Implied Action
RSI (14)
25.02
Buy
STOCH (9,6)
11.90
Buy
STOCHRSI (14)
18.14
Buy
MACD (12,26)
-0.96
Sell
ADX (14)
32.18
Neutral
Williams %R
-100.00
Buy
CCI (14)
-229.70
Buy
ATR (14)
0.86
-
Ultimate Oscillator
37.48
Neutral
ROC
-7.78
Sell
Prothena’s (PRTA) Relative Strength Index (RSI) is 25.02, creating a Buy signal.
Prothena’s (PRTA) Trend Strength Indicator (ADX) is 32.18, creating a Neutral signal.
Prothena’s (PRTA) Commodity Channel Index (CCI) is -229.70, creating a Buy signal.
Prothena’s (PRTA) Price Rate of Change (ROC) is -7.78, creating a Sell signal.

FAQ

Is PRTA a Buy, Hold, or Sell?
Based on PRTA’s technical indicators, PRTA is a Sell.
    What is PRTA’s RSI (14)?
    PRTA’s RSI (14) is 25.02, which suggests PRTA is a Buy.
      What is PRTA’s MACD?
      PRTA’s MACD is -0.96, which suggests PRTA is a Sell.
        What is PRTA’s 5-day moving average?
        PRTA’s 5-day moving average is 16.24, which suggests PRTA is a Sell.
          What is PRTA’s 20-day moving average?
          PRTA 20-day moving average is 16.71, which suggests PRTA is a Sell.
            What is PRTA’s 50-day moving average?
            PRTA’s 50-day moving average is 19.44, which suggests PRTA is a Sell.
              What is PRTA’s 200-day moving average?
              PRTA’s 200-day moving average is 23.02, which suggests PRTA is a Sell.
                What is PRTA’s Williams % R (14)?
                PRTA’s Williams % R (14) is -100.00, which suggests PRTA is a Buy.
                  What is PRTA’s CCI (14)?
                  PRTA’s CCI (14) is -229.70, which suggests PRTA is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis